Previous Close | 0.5500 |
Open | 0.5500 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 27.50 |
Expire Date | 2024-05-17 |
Day's Range | 0.5500 - 0.5500 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Challenging Economic Conditions Impact Profitability Amidst Revenue Increase
LAKE FOREST, Calif., May 07, 2024--STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the first quarter ended March 29, 2024.